Skip to main content
. 2018 Mar 9;118(8):1084–1088. doi: 10.1038/s41416-018-0005-1

Fig. 1.

Fig. 1

DCTD and RRM1 immunhistochemistry scoring. Representative images of DCTD negative (a), weak (b), moderate (c), and strong (d) expressing tumours, and RRM1 negative (e), weak (f), moderate (g) and strong (h) expressing tumours, respectively